Cantaloupe (USAT) Competitors $8.03 +0.05 (+0.63%) (As of 10/8/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsTrends USAT vs. DBD, PAR, FTGC, FTSL, SLQD, FMB, IBTE, QQEW, FALN, and BCATShould you be buying Cantaloupe stock or one of its competitors? The main competitors of Cantaloupe include Diebold Nixdorf (DBD), PAR Technology (PAR), First Trust Global Tactical Commodity Strategy Fund (FTGC), First Trust Senior Loan ETF (FTSL), iShares 0-5 Year Investment Grade Corporate Bond ETF (SLQD), First Trust Managed Municipal ETF (FMB), iShares iBonds Dec 2024 Term Treasury ETF (IBTE), First Trust NASDAQ 100 Equal Weighted Index Fund (QQEW), iShares Fallen Angels USD Bond ETF (FALN), and BlackRock Capital Allocation Term Trust (BCAT). Cantaloupe vs. Diebold Nixdorf PAR Technology First Trust Global Tactical Commodity Strategy Fund First Trust Senior Loan ETF iShares 0-5 Year Investment Grade Corporate Bond ETF First Trust Managed Municipal ETF iShares iBonds Dec 2024 Term Treasury ETF First Trust NASDAQ 100 Equal Weighted Index Fund iShares Fallen Angels USD Bond ETF BlackRock Capital Allocation Term Trust Diebold Nixdorf (NYSE:DBD) and Cantaloupe (NASDAQ:USAT) are both small-cap computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, media sentiment, community ranking, dividends and earnings. Which has stronger valuation & earnings, DBD or USAT? Diebold Nixdorf has higher revenue and earnings than Cantaloupe. Cantaloupe is trading at a lower price-to-earnings ratio than Diebold Nixdorf, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDiebold Nixdorf$3.56B0.47$1.38B$5.837.70Cantaloupe$150.91M3.78-$34.12M-$0.48-16.73 Is DBD or USAT more profitable? Diebold Nixdorf has a net margin of 56.28% compared to Cantaloupe's net margin of 0.00%. Diebold Nixdorf's return on equity of 226.25% beat Cantaloupe's return on equity.Company Net Margins Return on Equity Return on Assets Diebold Nixdorf56.28% 226.25% 58.15% Cantaloupe N/A N/A N/A Do institutionals & insiders hold more shares of DBD or USAT? 97.0% of Diebold Nixdorf shares are held by institutional investors. Comparatively, 61.6% of Cantaloupe shares are held by institutional investors. 0.0% of Diebold Nixdorf shares are held by company insiders. Comparatively, 18.8% of Cantaloupe shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the MarketBeat Community favor DBD or USAT? Diebold Nixdorf received 448 more outperform votes than Cantaloupe when rated by MarketBeat users. Likewise, 58.72% of users gave Diebold Nixdorf an outperform vote while only 0.00% of users gave Cantaloupe an outperform vote. CompanyUnderperformOutperformDiebold NixdorfOutperform Votes44858.72% Underperform Votes31541.28% CantaloupeOutperform VotesNo VotesUnderperform Votes126100.00% Which has more volatility & risk, DBD or USAT? Diebold Nixdorf has a beta of 2.18, indicating that its stock price is 118% more volatile than the S&P 500. Comparatively, Cantaloupe has a beta of 2.25, indicating that its stock price is 125% more volatile than the S&P 500. Does the media prefer DBD or USAT? In the previous week, Diebold Nixdorf had 6 more articles in the media than Cantaloupe. MarketBeat recorded 7 mentions for Diebold Nixdorf and 1 mentions for Cantaloupe. Diebold Nixdorf's average media sentiment score of 0.57 beat Cantaloupe's score of 0.00 indicating that Diebold Nixdorf is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Diebold Nixdorf 2 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cantaloupe 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts rate DBD or USAT? Diebold Nixdorf presently has a consensus price target of $57.50, indicating a potential upside of 28.41%. Given Diebold Nixdorf's higher possible upside, analysts plainly believe Diebold Nixdorf is more favorable than Cantaloupe.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Diebold Nixdorf 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Cantaloupe 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A SummaryDiebold Nixdorf beats Cantaloupe on 14 of the 17 factors compared between the two stocks. Ad Crypto 101 Media[SHOCKING] Crypto Document Leak…The crypto market waits for no one. And my team of experts and I believe that a BIG move is right around the corner. That's why we're offering you instant access to the game-changing book that's transforming average investors into massive crypto successes.Download your digital copy now Get Cantaloupe News Delivered to You Automatically Sign up to receive the latest news and ratings for USAT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding USAT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat are MarkeBeat Followers?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart USAT vs. The Competition Export to ExcelMetricCantaloupeComputer Storage Device Manufacturing IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$570.76M$570.76M$2.34B$8.48BDividend YieldN/AN/A2.52%4.13%P/E Ratio-16.73N/A26.6518.51Price / Sales3.783.78561.5373.77Price / CashN/AN/A40.2233.23Price / BookN/AN/A2.214.79Net Income-$34.12MN/A$257.43M$224.84M7 Day Performance2.03%2.03%-0.05%2.26%1 Month Performance25.67%25.67%3.32%11.56%1 Year Performance15.54%15.54%13.71%19.68% Cantaloupe Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)USATCantaloupeN/A$8.03+0.6%N/A+15.9%$570.76M$150.91M-16.73N/AAnalyst ForecastNews CoverageDBDDiebold Nixdorf4.8736 of 5 stars$44.26+3.7%$57.50+29.9%+144.6%$1.66B$3.56B7.5921,000Gap UpPARPAR Technology0.4729 of 5 stars$52.65+1.9%$58.00+10.2%+41.2%$1.79B$425.93M-20.491,841FTGCFirst Trust Global Tactical Commodity Strategy FundN/A$24.19-0.2%N/A+2.4%$2.25BN/A0.00147,000FTSLFirst Trust Senior Loan ETFN/A$46.09+0.2%N/A+1.3%$2.23BN/A0.00147,000SLQDiShares 0-5 Year Investment Grade Corporate Bond ETFN/A$50.07-0.3%N/A+4.7%$2.10BN/A0.00147,000FMBFirst Trust Managed Municipal ETFN/A$51.81-0.4%N/A+6.8%$2.03BN/A0.00147,000Positive NewsIBTEiShares iBonds Dec 2024 Term Treasury ETFN/A$23.91flatN/A+0.6%$1.96BN/A0.00147,000QQEWFirst Trust NASDAQ 100 Equal Weighted Index FundN/A$125.42+1.1%N/A+20.5%$1.95BN/A30.27147,000News CoverageFALNiShares Fallen Angels USD Bond ETFN/A$27.15-0.1%N/A+11.1%$1.85BN/A0.00147,000BCATBlackRock Capital Allocation Term TrustN/A$16.46+0.5%N/A+14.3%$1.77B$211.29M0.00147,000Insider SellingNews Coverage Related Companies and Tools Related Companies: Diebold Nixdorf Alternatives PAR Technology Alternatives First Trust Global Tactical Commodity Strategy Fund Alternatives First Trust Senior Loan ETF Alternatives iShares 0-5 Year Investment Grade Corporate Bond ETF Alternatives First Trust Managed Municipal ETF Alternatives iShares iBonds Dec 2024 Term Treasury ETF Alternatives First Trust NASDAQ 100 Equal Weighted Index Fund Alternatives iShares Fallen Angels USD Bond ETF Alternatives BlackRock Capital Allocation Term Trust Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:USAT) was last updated on 10/9/2024 by MarketBeat.com Staff From Our PartnersWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredBigger Than Nvidia?Bigger Than Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the n...InvestorPlace | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored[SHOCKING] Crypto Document Leak…A shocking leak has revealed Japanese electronics giant Sony is now starting its own blockchain. This move ...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredAI Expert Reveals New PickYour Financial Planner Won't Tell You About This Investment Strategy Silicon Valley insider Jeff Brown has ...Brownstone Research | SponsoredClaim Your FREE "AI Income Playbook" Now!Income expert Marc Lichtenfeld has a special gift reserved just for you... It's his brand-new "AI Income Pl...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cantaloupe Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Cantaloupe With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.